Maciej Daniszewski,
Researcher,
University of Melbourne
Maciej Daniszewski obtained his MsC in Biotechnology from the University of Warsaw in 2015 and subsequently joined Associate Professor Alice Pébay at the Centre for Eye Research Australia. Currently, he pursues a PhD at the University of Melbourne working on a large-scale glaucoma disease-modelling project using the custom-made automated platform. So far, 300 iPSC lines have been generated on the platform with another 250 planned in 2018. He has already published 7 original papers and is the inventor of one international patent related to stem cell technology and automation.
Human Induced Pluripotent Stem (iPS) Cells in Glaucoma Modeling with an Automated Platform and 3D Retinal Organoids
Friday, 14 June 2019 at 16:00
Add to Calendar ▼2019-06-14 16:00:002019-06-14 17:00:00Europe/LondonHuman Induced Pluripotent Stem (iPS) Cells in Glaucoma Modeling with an Automated Platform and 3D Retinal Organoids3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Glaucoma is a disease characterized by slow degeneration of retinal ganglion cells (RGCs) what leads to irreversible vision loss and may ultimately result in blindness. It is estimated that approximately 80 million people will be affected by the disease in 2020, and with aging populations, this number will only continue to grow, thus generating a significant financial burden on the healthcare system.
Nevertheless, its exact molecular mechanism remains elusive. The use of human pluripotent stem cells (hPSCs) and three-dimensional (3D) organoids may bring a long-awaited breakthrough. Organoids mimic the organization and physiology of the tissue and thus recapitulate the disease phenotype more closely than 2D models. Organoid-derived RGCs may help to extend our understanding of mechanisms that confer risk of developing the disease, but also those that govern its progression.
Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2019-06-14 16:00:002019-06-14 17:00:00Europe/LondonHuman Induced Pluripotent Stem (iPS) Cells in Glaucoma Modeling with an Automated Platform and 3D Retinal Organoids3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
